Nate Massari

About Nate Massari

Nate Massari brings 25 years of experience across commercialization, strategy, and corporate development in the biopharmaceutical industry. Nate is currently a Managing Director at Deloitte in the Life Sciences and Health Care Practice. He recently served as Chief Business Officer for genetic medicines startup Anjarium Biosciences, leading to the sale of the company. Previously, he co-founded rare disease startup Rumpus Therapeutics, culminating in the sale to Aytu BioPharma where he was Executive Vice President of Rare Disease Operations. Nate’s extensive leadership experience includes key roles at Johnson & Johnson, AstraZeneca, Endo Pharmaceuticals, and Cencora. He has orchestrated numerous business development transactions totaling over $6 billion in capital and his rare disease expertise includes launching pediatric inflammatory bowel disease indications as well as leading an orphan drug pediatric endocrinology franchise. Nate began his career in management consulting in the Health and Life Sciences practice at Accenture. He holds a BA from Princeton University and earned his MBA from the Wharton School at the University of Pennsylvania.

Experience

1. Managing Director in Life Sciences and Health Care Practice

   Deloitte

   Jan 2025 — Present · Philadelphia, PA, US

Education

• The Wharton School

  MBA

  2004 — 2006

• Princeton University

  BA

  1996 — 2000

Skills

• Strategy
• Biotechnology
• Business Strategy
• Managed Care
• Lifesciences
• Marketing
• Enterprise Software
• Healthcare
• Consulting
• Sales Management
• Gastroenterology
• Sales
• Global Marketing
• Immunology
• Hospital Sales
• Pharmaceutics
• Pharmaceutical Industry
• Pharmaceutical Sales
• Medical Devices
• Cross-Functional Team Leadership
• Product Development
• Business Analysis
• Product Launch
• Cross-Functional Coordination
• New Business Development
• Marketing Strategy
• Commercialization
• Product Management
• Team Leadership